Advertisement
Journal Home
Search for

Volume 46, Issue 3, Pages 190-194 (March 2010)


View previous. 10 of 15 View next.

Study of the length of hospital stay for free flap reconstruction of oral and pharyngeal cancer in the context of the new French casemix-based funding

Angélique GirodCorresponding Author Informationemail address, Antonio Brancati, Véronique Mosseri, Irène Kriegel, Thomas Jouffroy, José Rodriguez

Received 19 November 2009; received in revised form 3 December 2009; accepted 3 December 2009. published online 11 January 2010.

Summary 

The French national health insurance reimbursement system has recently changed from a global hospital funding system to casemix-based funding. The authors studied the factors likely to influence the length of hospital stay for free flap reconstructions after surgery for cancers of the oral cavity or pharynx.

Data concerning 207 oral cavity or pharynx free flap reconstructions were extracted from a prospective registration. Lengths of hospital stay were compared by an analysis of variance F test or a nonparametric Kruskal–Wallis test, and transfusion rates were compared by Chi-square test or Fisher’s exact test, as appropriate.

The median length of hospital stay was 24days (range: 7–145days). Length of hospital stay was significantly longer according to the type of flap (p<0.005), in N2–N3 patients (p<0.02), a PINI score more than 10, a 3–4 American Society of Anesthesiologists (ASA) score, the presence of a tracheotomy and in patients requiring transfusion (p<0.0001).

As the nodal status, the American Society of Anesthesiologists (ASA) score of the patient, the need of tracheotomy and the type of flap cannot be corrected, the management of preoperative haemoglobin and nutritional status are the sole factors which can improve the length of hospital stay. In the context of the new casemix-based funding, this study raises the problem of harvesting of the fibula flap, management of preoperative haemoglobin and nutritional status.

Head and Neck Oncologic Surgery Unit, Institut Curie, 26 rue d’Ulm, 75005 Paris, France

Corresponding Author InformationCorresponding author. Tel.: +33 1 44 32 45 30; fax: +33 1 44 32 45 32.

PII: S1368-8375(09)00987-7

doi:10.1016/j.oraloncology.2009.12.002


View previous. 10 of 15 View next.

Advertisement